The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome
Open accessAbstract
BACKGROUND: Hallervorden-Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase-associated neurodegeneration. In this study, we compared the clinical and radiographic features of patients with Hallervorden-Spatz syndrome with and without mutations in PANK2. METHODS: One hundred twenty-three patients from 98 families with a diagnosis of Hallervorden-Spatz syndrome were classified on the basis of clinical assessment as having classic disease (characterized by early onset with rapid progression) or atypical disease (later onset with slow progression). Their genomic DNA was sequenced for PANK2 mutations. RESULTS: All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations. Whereas almost all mutations in patients with atypical disease led to amino acid changes, those in patients with classic disease more often resulted in predicted protein truncation. Patients with atypical disease who had PANK2 mutations were more likely to have prominent speech-related and psychiatric symptoms than patients with classic disease or mutation-negative patients with atypical disease. In all patients with pantothenate kinase-associated neurodegeneration, whether classic or atypical, T2-weighted magnetic resonance imaging (MRI) of the brain showed a specific pattern of hyperintensity within the hypointense medial globus pallidus. This pattern was not seen in any patients without mutations. CONCLUSIONS: PANK2 mutations are associated with all cases of classic Hallervorden-Spatz syndrome and one third of cases of atypical disease. A specific MRI pattern distinguishes patients with PANK2 mutations. Predicted levels of pantothenate kinase 2 protein correlate with the severity of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Self-citationCurtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Dooling, E. C., Schoene, W. C., & Richardson, E. P. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310072012 · Cited by 269
Hallervorden, J., & Spatz, H. (1922) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02878455 · Cited by 253
Hallervorden‐spatz syndrome: Clinical and magnetic resonance imaging correlations
Sethi, K. D., Adams, R. J., Loring, D. W., & El Gammal, T. (1988) · Annals of Neurology · doi:10.1002/ana.410240519 · Cited by 198
Hallervorden-Spatz Syndrome and Brain Iron Metabolism
Swaiman, K. F. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240091029 · Cited by 196
Gitlin, J. D. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00001 · Cited by 171
Late‐onset Hallervorden‐Spatz disease presenting as familial parkinsonism
Jankovic, J. J., Kirkpatrick, J. B., Blomquist, K. A., Langlais, P. J., & Bird, E. D. (1985) · Neurology · doi:10.1212/wnl.35.2.227 · Cited by 108
HARP syndrome is allelic with pantothenate kinase–associated neurodegeneration
Ching, K. H. L., Westaway, S. K., Gitschier, J. M., Higgins, J. J., & Hayflick, S. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1673 · Cited by 106
Self-citationRacial hygiene, active euthanasia, and Julius Hallervorden
Shevell, M. I. (1992) · Neurology · doi:10.1212/wnl.42.11.2214 · Cited by 79
The nosology of Hallervorden-Spatz disease
HALLIDAY, W. C. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00212-k · Cited by 64
Luckenbach, M. W., Green, W. R., Miller, N. R., Moser, H. W., Clark, A. W., & Tennekoon, G. I. (1983) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)78308-4 · Cited by 57
Nardocci, N., Rumi, V., Combi, M. L., Angelini, L., Mirabile, D., & Bruzzone, M. G. (1994) · Movement Disorders · doi:10.1002/mds.870090322 · Cited by 35
Hallervorden-Spatz disease in a psychiatric setting.
Morphy, M. A., Feldman, J. A., & Kilburn, G. (1989) · PubMed · Cited by 34
Über eien familiälle Erkrankug im extrapyramidalen System
Hallervorden, S. (1924) · Journal of Neurology · doi:10.1007/bf01669546 · Cited by 23
Cited by
LEONARDI, R., ZHANG, Y., ROCK, C., & JACKOWSKI, S. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.04.001 · Cited by 644
Iron Overload in Human Disease
Fleming, R. E., & Ponka, P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1004967 · Cited by 587
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Coryell, J., Canham, N., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 533
Self-citationCharacterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Metadata
- Authors
- Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H. L., & Gitschier, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-02
- Volume
- 348
- Issue
- 1
- Pages
- 33-40
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102239505
- Cited by
- 714
- References
- 15
- FWCI
- 22.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.